- Research works
- 0 fractional, all time
- Citations
- 18 47.4 per fractional work
- Top-10% rate
- 86.8% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Saudi Pharmaceutical Society is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Saudi Pharmaceutical Society publish most on?
By volume: COVID-19 Pandemic Impacts, Pharmaceutical Economics and Policy, Healthcare Systems and Reforms and Meta-analysis and systematic reviews.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 COVID-19 Pandemic Impacts Economics and Econometrics 0 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 3 Healthcare Systems and Reforms Finance 0 works
- 4 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 0 works
- 5 Health Policy Implementation Science General Health Professions 0 works
- 6 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Riyadh
- King Saud University
- King Faisal Specialist Hospital & Research Centre
- Princess Nourah bint Abdulrahman University
- Imam Mohammad ibn Saud Islamic University
- King Saud bin Abdulaziz University for Health Sciences
- Prince Sultan University
- Majmaah University
- National Guard Health Affairs
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.